1. Home
  2. GLP vs NUVB Comparison

GLP vs NUVB Comparison

Compare GLP & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$48.40

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo Nuvation Bio Inc.

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.58

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
NUVB
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GLP
NUVB
Price
$48.40
$4.58
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
43.9K
★ 5.0M
Earning Date
11-06-2026
11-04-2026
Dividend Yield
★ 6.43%
N/A
EPS Growth
N/A
★ 71.56
EPS
★ N/A
N/A
Revenue
★ $18,561,421,000.00
$62,902,000.00
Revenue This Year
$47.70
$211.79
Revenue Next Year
$23.62
$45.15
P/E Ratio
$23.28
★ N/A
Revenue Growth
8.14
★ 698.96
52 Week Low
$39.58
$3.92
52 Week High
$54.29
$9.75

Technical Indicators

Market Signals
Indicator
GLP
NUVB
Relative Strength Index (RSI) 47.85 33.93
Support Level $45.67 $4.10
Resistance Level $50.74 $5.16
Average True Range (ATR) 1.36 0.24
MACD 0.14 0.03
Stochastic Oscillator 50.81 33.57

Price Performance

Historical Comparison
GLP
NUVB

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: